As constituents of Averrhoa bilimbi leaves we identified three new compounds (1-3) together with 12 known ones (4-15); their inhibitory activities on cytochrome P450 3A4 (CYP3A4) and 2D6 (CYP2D6) were examined. Among the isolated compounds, the mixture of 1 and 2, and compounds 4 and 9 showed strong inhibition on CYP3A4, but mild or no inhibition on CYP2D6. These compounds revealed the characteristics of 1) time- and concentration-dependent inhibition, 2) requirement of NADPH for the inhibition, 3) no protection by nucleophiles, and 4) suppression of the inhibition by competitive inhibitor. Thus, they are suggested to be mechanism-based inactivators of CYP3A4 and CYP2D6. The kinetic parameters for the inactivation (kinact and KI) were 0.19 min–1 and 36.7 μM for the mixture of 1 and 2, 0.126 min–1 and 10.5 μM for 4, and 0.29 min–1 and 23.4 μM for 9.
GuengerichFP. (1996) In vitro techniques for studying drug metabolism. Journal of Pharmacokinetic and Biopharmaceutics, 24, 521–533.
3.
de MontellanoPRO, CorreiaMA. (2005) Inhibition of cytochrome P450 enzymes. In Cytochrome P450, structure, mechanism, and biochemistry. de MontellanoPRO. (Ed). Kluwer Academic, New York, USA, 247–322.
4.
ClarkeSE, JonesBC. (2002) Human cytochromes P450 and their role in metabolism-based drug–drug interactions. In Drug–drug interactions. RodriguesAD. (Ed). Marcel Dekker, New York, USA, 55–58.
5.
LinJH, LuAYH. (1998) Inhibition and induction of cytochrome P450 and the clinical implication. Clinical Pharmacokinetics, 35, 361–390.
6.
SilvermanRB. (1988) Mechanism-based enzyme inactivation: chemistry and enzymology I. CRC Press, Florida, USA, 1–30.
BaileyCJ, DayC. (1989) Traditional plant medicines as treatments for diabetes. Diabetes Care, 12, 553–564.
9.
PusparajP, TanCH, TanBKH. (2000) Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. Journal of Ethnopharmacology, 72, 69–76.
10.
TanBKH, TanCH, PusparajPN. (2005) Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sciences, 76, 2827–2839
11.
PusparajPN, TanBKH, TanCH. (2001) The mechanism of hypoglycemic action of the semi-purified fractions of Averrhoa bilimbi in streptozotocin-diabetic rats. Life Sciences, 70, 535–547.
12.
HosoiS, ShimizuE, ArimoriK, OkumuraM, HidakaM, YamadaM, SakushimaA. (2008) Analysis of CYP3A inhibitory components of star fruit (Averrhoa carambola L.) using liquid chromatography–mass spectrometry. Journal of Natural Medicines, 62, 345–348.
13.
AkihisaT, YamamotoK, TamuraT, KimuraY, IidaT, NambaraT, ChangFC. (1992) Triterpenoid ketones from Lingnania chungii McClure: arborinone, friedelin and glutinone. Chemical & Pharmaceutical Bulletin, 40, 789–791.
14.
KnightSA. (1974) Carbon-13 NMR spectra of some tetra- and pentacyclic triterpenoids. Organic Magnetic Resonance, 6, 603–611.
15.
GoodmanRA, OldfieldE, AllerhandA. (1973) Assignment in the natural-abundance carbon-13 nuclear magnetic resonance spectrum of chlorophyll a and a study of segmental motion in neat phytol. Journal of American Chemical Society, 23, 7553–7557.
16.
RubinsteinI, GoadLJ, ClagueADH, MulheirnLJ. (1976) The 220 MHz NMR spectra of phytosterols. Phytochemistry, 15, 195–200.
BanerjiA, RayR. (1981) Aurantiamides: a new class of modified dipeptides from Piper aurantiacum. Phytochemistry, 20, 2217–2220.
19.
OwenRW, HaubnerR, MierW, GiacosaA, HullWE, SpiegelhalderB, BartschH. (2003) Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes. Food and Chemical Toxicology, 41, 703–717.
20.
SerraS, BarakatA, FugantiC. (2007) Chemoenzymatic resolution of cis- and trans-3,6-dihydroxy-α-ionone. Synthesis of the enantiomeric forms of dehydrovomifoliol and 8,9-dehydrotheaspirone. Tetrahedron: asymmetry, 18, 2573–2580.
21.
OkadaN, ShirataK, NiwanoM, KoshinoH, UramotoM. (1994) Immunosupressive activity of a monoterpene from Eucommia ulmoides. Phytochemistry, 37, 281–282.
22.
ArahoD, MiyakoshiM, ChuoWH, KambaraT, MizutaniK, IkedaT. (2005) A new flavone C-glycoside from the leaves of Averrhoa carambola. Natural Medicines, 59, 113–116.
23.
MabryTJ, MarkhamKR, ThomasMB. (1970) The systematic identification of flavonoids. Springer-Verlag, New York, USA, 41–230.
24.
LinNR, TanakaT, ZhouJ, TanakaO. (1982) Phlorizin and trilobatin, sweet dihydrochalcone-glucosides from leaves of Lithocarpus litseifolius (Hance) Rehd. (Fagaceae). Agricultural & Biological Chemistry, 46, 1933–1934
25.
TanakaT, YamasakiK, KohdaH, TanakaO. (1980) Dihydrochalcone-glucosides as sweet principles of Symplocos ssp. Planta Medica, 40, 81–83.
26.
MontoroP, CarboneV, SimoneFD, PizzaC, TommasiND. (2001) Studies on the constituents of Cyclanthera pedata fruits: isolation and structure elucidation of new flavonoid glycosides and their antioxidant activity. Journal of Agricultural & Food Chemistry, 49, 5156–5160.
27.
von MoltkeLL, GreenblattDJ, DuanSX, HarmatzJS, ShaderRI. (1994) In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction. Journal of Clinical Pharmacology, 34, 1222–1227.
28.
LabroRB, ThummelKE, KunzeKL, PodollT, TragerWF, KharaschED. (1995) Catalytic role of cytochrome P450 3A4 in multiple pathways of alfentanil metabolism. Drug Metabolism & Disposition, 23, 490–496.
29.
NelsonSD. (1982) Metabolic activation and drug toxicity. Journal of Medicinal Chemistry, 25, 753–765.
30.
Moruno-DávilaMA, SoloCG, García-MorenoM, HavsteenBH, Garcia-SevillaF, Garcia-CánovasF, VarónR. (2001) Kinetic analysis of enzyme systems with suicide substrate in the presence of a reversible competitive inhibitor, tested by simulated progress curves. The International Journal of Biochemistry & Cell Biology, 33, 181–191.
TassaneeyakulW, GuoLQ, FukudaK, OhtaT, YamazoeY. (2000) Inhibition selectivity of grapefruit juice components on human cytochromes P450. Archives of Biochemistry and Biophysics, 374, 356–363.
33.
IwataH, TezukaY, KadotaS, HiratsukaA, WatabeT. (2004) Identification and characterization of the potent CYP3A4 inhibitors in Schisandra fruit extract. Drug Metabolism and Disposition, 32, 1351–1358
34.
IwataH, TezukaY, KadotaS, HiratsukaA, WatabeT. (2005) Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Drug Metabolism and Pharmacokinetics, 20, 34–45
35.
VoormanRL, MaioSM, PayneNA, ZhaoZ, KoeplingerKA, WangX. (1998) Microsomal metabolism of delavirdine: evidence from mechanism-based inactivator of human cytochrome P450 3A. Journal of Pharmacology and Experimental Therapeutics, 287, 381–388
36.
KentUM, AviramM, RosenblatM, HollenbergPF. (2002) The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Drug Metabolism and Disposition, 30, 709–715
37.
Subehan ZaidiSFH, KadotaS, TezukaY. (2007) Inhibition on human liver cytochrome P450 3A4 by constituent of fennel (Foeniculum vulgare): identification and characterization of a mechanism-based inactivator. Journal of Agricultural & Food Chemistry, 55, 10162–10167.
38.
CrespiCL, StresserDM. (2000) Fluorometric screening for metabolism-based drug-drug interactions. Journal of Pharmacological and Toxicological Methods, 44, 325–331.
